Search - Prime Therapeutics
-
Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more
PA Sub-Categories: Specialty drugs Prime Article: Stories -
New report highlights value-based contract solution and analysis of top 10 drug classes impacting Medicaid pharmacy net trend
PA Sub-Categories: Specialty drugs Products Prime Article: Stories -
oncology insights Oncology Insights: 2024 Rewind January 16, 2025 Last year, Oncology Insights brought you the most talked about topics in 2024. As we enter this new year, let us review these...
-
Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023
PA Sub-Categories: Specialty drugs Prime Article: Stories -
Perspectives High-Cost Therapy Profile: June 2024 Detailed information about Imetelstat Intravenous (IV) June 14, 2024 High Cost Therapy Profile Oncology Imetelstat Intravenous (IV) Geron Proposed...
-
publications 2024 Employer Market Insights Report June 28, 2024 Prime is pleased to present the seventh edition of the Employer Market Insights Report. Within this one-of-a-kind publication,...
-
Cover image for FDA Decisions Expected_February 2025 Drug pipeline for February 2025 Prime Therapeutics /fda-decisions-expected-february-2025 About Prime Therapeutics Prime Therapeutics logo Prime...
Prime Article: Research & Publications PA Research & Publications: FDA Decisions Expected